Cardiovascular Responses to Spartathlon Running (Spartathlon)
Primary Purpose
Disorder Heart
Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
246-km running
Sponsored by

About this trial
This is an interventional screening trial for Disorder Heart
Eligibility Criteria
Inclusion Criteria:
- Runners at least 18 years old, healthy and sufficiently trained.
- Runners being accepted to participate in the Spartathlon race according to the eligibility criteria (http://www.spartathlon.gr/en/registration-en.html)
- Runners who will volunteer to be examined pre- and post the race
Exclusion Criteria:
- Runners with chronic diseases
- Runners receiving any medication
Sites / Locations
- Laboratory of Sports Medicine
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Athletes
Arm Description
246-km running
Outcomes
Primary Outcome Measures
Change of right ventricular function after one day ultra-marathon running
Echocardiographic study of left ventricular function
Secondary Outcome Measures
Change of left ventricular function after one day ultra-marathon running
Echocardiographic study of left ventricular function
Change of carotid artery function after one day ultra-marathon running
Echocardiographic study of carotid arteries
Full Information
NCT ID
NCT03304483
First Posted
September 28, 2017
Last Updated
July 19, 2023
Sponsor
Aristotle University Of Thessaloniki
1. Study Identification
Unique Protocol Identification Number
NCT03304483
Brief Title
Cardiovascular Responses to Spartathlon Running
Acronym
Spartathlon
Official Title
Cardiovascular Effects of Ultramarathon Running
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
September 29, 2017 (Actual)
Primary Completion Date
December 30, 2019 (Actual)
Study Completion Date
June 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aristotle University Of Thessaloniki
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The aim of this study is to examine the cardiovascular effects of ultramarathon running and their relation to performance.
Detailed Description
The purpose of the study is to determine the changes of cardiovascular morphology and function after an ultramarathon race. 50 entrants to the "Spartathlon 2017" 246-km running race will participate in the study. Cardiac and arterial morphology and function tests will be conducted one day before the race and within 20 minutes of race completion.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Disorder Heart
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
athletes participating in the ultra marathon running
Masking
None (Open Label)
Masking Description
Before and after the race
Allocation
N/A
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Athletes
Arm Type
Experimental
Arm Description
246-km running
Intervention Type
Other
Intervention Name(s)
246-km running
Intervention Description
Spartathlon 2017
Primary Outcome Measure Information:
Title
Change of right ventricular function after one day ultra-marathon running
Description
Echocardiographic study of left ventricular function
Time Frame
before and after 1 day running
Secondary Outcome Measure Information:
Title
Change of left ventricular function after one day ultra-marathon running
Description
Echocardiographic study of left ventricular function
Time Frame
before and after 1 day running
Title
Change of carotid artery function after one day ultra-marathon running
Description
Echocardiographic study of carotid arteries
Time Frame
before and after 1 day running
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
67 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Runners at least 18 years old, healthy and sufficiently trained.
Runners being accepted to participate in the Spartathlon race according to the eligibility criteria (http://www.spartathlon.gr/en/registration-en.html)
Runners who will volunteer to be examined pre- and post the race
Exclusion Criteria:
Runners with chronic diseases
Runners receiving any medication
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Evangelia Kouidi, Professor
Organizational Affiliation
Aristotle University of Thessaloniki, Greece
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laboratory of Sports Medicine
City
Thessaloniki
ZIP/Postal Code
546 35
Country
Greece
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No personal details will be shared. Only the results of the measurements will be available
Citations:
PubMed Identifier
17219787
Citation
Seedhouse EL, Walsh ML, Blaber AP. Heart rate, mean arterial blood pressure, and pulmonary function changes associated with an ultraendurance triathlon. Wilderness Environ Med. 2006 Winter;17(4):240-5. doi: 10.1580/pr27-05-r1.1.
Results Reference
background
PubMed Identifier
22812424
Citation
Millet GP, Millet GY. Ultramarathon is an outstanding model for the study of adaptive responses to extreme load and stress. BMC Med. 2012 Jul 19;10:77. doi: 10.1186/1741-7015-10-77.
Results Reference
background
PubMed Identifier
25010150
Citation
Cote AT, Phillips AA, Foulds HJ, Charlesworth SA, Bredin SS, Burr JF, Koehle MS, Warburton DE. Sex differences in cardiac function after prolonged strenuous exercise. Clin J Sport Med. 2015 May;25(3):276-83. doi: 10.1097/JSM.0000000000000130.
Results Reference
background
PubMed Identifier
23685440
Citation
Jee H, Park J, Oh JG, Lee YH, Shin KA, Kim YJ. Effect of a prolonged endurance marathon on vascular endothelial and inflammation markers in runners with exercise-induced hypertension. Am J Phys Med Rehabil. 2013 Jun;92(6):513-22. doi: 10.1097/PHM.0b013e31829232db.
Results Reference
background
PubMed Identifier
15507692
Citation
Blaber AP, Walsh ML, Carter JB, Seedhouse EL, Walker VE. Cardiopulmonary physiology and responses of ultramarathon athletes to prolonged exercise. Can J Appl Physiol. 2004 Oct;29(5):544-63. doi: 10.1139/h04-035.
Results Reference
result
Learn more about this trial
Cardiovascular Responses to Spartathlon Running
We'll reach out to this number within 24 hrs